Eintrag weiter verarbeiten
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
Gespeichert in:
Zeitschriftentitel: | Antimicrobial Agents and Chemotherapy |
---|---|
Personen und Körperschaften: | , , , |
In: | Antimicrobial Agents and Chemotherapy, 26, 1984, 4, S. 580-582 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
American Society for Microbiology
|
Schlagwörter: |
author_facet |
Aronoff, S C Jacobs, M R Johenning, S Yamabe, S Aronoff, S C Jacobs, M R Johenning, S Yamabe, S |
---|---|
author |
Aronoff, S C Jacobs, M R Johenning, S Yamabe, S |
spellingShingle |
Aronoff, S C Jacobs, M R Johenning, S Yamabe, S Antimicrobial Agents and Chemotherapy Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin Infectious Diseases Pharmacology (medical) Pharmacology |
author_sort |
aronoff, s c |
spelling |
Aronoff, S C Jacobs, M R Johenning, S Yamabe, S 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.26.4.580 <jats:p>YTR 830, a new beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam against aminopenicillin-resistant clinical isolates. At a concentration of 8 micrograms/ml, YTR 830 was as effective as clavulanate or sulbactam in reducing the aminopenicillin MICs. Combined with amoxicillin, YTR 830 is a potentially useful agent for therapy of many bacterial infections.</jats:p> Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin Antimicrobial Agents and Chemotherapy |
doi_str_mv |
10.1128/aac.26.4.580 |
facet_avail |
Online Free |
finc_class_facet |
Medizin Chemie und Pharmazie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMjYuNC41ODA |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMjYuNC41ODA |
institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
imprint |
American Society for Microbiology, 1984 |
imprint_str_mv |
American Society for Microbiology, 1984 |
issn |
0066-4804 1098-6596 |
issn_str_mv |
0066-4804 1098-6596 |
language |
English |
mega_collection |
American Society for Microbiology (CrossRef) |
match_str |
aronoff1984comparativeactivitiesofthebetalactamaseinhibitorsytr830sodiumclavulanateandsulbactamcombinedwithamoxicillinorampicillin |
publishDateSort |
1984 |
publisher |
American Society for Microbiology |
recordtype |
ai |
record_format |
ai |
series |
Antimicrobial Agents and Chemotherapy |
source_id |
49 |
title |
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
title_unstemmed |
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
title_full |
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
title_fullStr |
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
title_full_unstemmed |
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
title_short |
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
title_sort |
comparative activities of the beta-lactamase inhibitors ytr 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
topic |
Infectious Diseases Pharmacology (medical) Pharmacology |
url |
http://dx.doi.org/10.1128/aac.26.4.580 |
publishDate |
1984 |
physical |
580-582 |
description |
<jats:p>YTR 830, a new beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam against aminopenicillin-resistant clinical isolates. At a concentration of 8 micrograms/ml, YTR 830 was as effective as clavulanate or sulbactam in reducing the aminopenicillin MICs. Combined with amoxicillin, YTR 830 is a potentially useful agent for therapy of many bacterial infections.</jats:p> |
container_issue |
4 |
container_start_page |
580 |
container_title |
Antimicrobial Agents and Chemotherapy |
container_volume |
26 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792336972494143493 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T15:08:54.718Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Comparative+activities+of+the+beta-lactamase+inhibitors+YTR+830%2C+sodium+clavulanate%2C+and+sulbactam+combined+with+amoxicillin+or+ampicillin&rft.date=1984-10-01&genre=article&issn=1098-6596&volume=26&issue=4&spage=580&epage=582&pages=580-582&jtitle=Antimicrobial+Agents+and+Chemotherapy&atitle=Comparative+activities+of+the+beta-lactamase+inhibitors+YTR+830%2C+sodium+clavulanate%2C+and+sulbactam+combined+with+amoxicillin+or+ampicillin&aulast=Yamabe&aufirst=S&rft_id=info%3Adoi%2F10.1128%2Faac.26.4.580&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792336972494143493 |
author | Aronoff, S C, Jacobs, M R, Johenning, S, Yamabe, S |
author_facet | Aronoff, S C, Jacobs, M R, Johenning, S, Yamabe, S, Aronoff, S C, Jacobs, M R, Johenning, S, Yamabe, S |
author_sort | aronoff, s c |
container_issue | 4 |
container_start_page | 580 |
container_title | Antimicrobial Agents and Chemotherapy |
container_volume | 26 |
description | <jats:p>YTR 830, a new beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam against aminopenicillin-resistant clinical isolates. At a concentration of 8 micrograms/ml, YTR 830 was as effective as clavulanate or sulbactam in reducing the aminopenicillin MICs. Combined with amoxicillin, YTR 830 is a potentially useful agent for therapy of many bacterial infections.</jats:p> |
doi_str_mv | 10.1128/aac.26.4.580 |
facet_avail | Online, Free |
finc_class_facet | Medizin, Chemie und Pharmazie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMjYuNC41ODA |
imprint | American Society for Microbiology, 1984 |
imprint_str_mv | American Society for Microbiology, 1984 |
institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
issn | 0066-4804, 1098-6596 |
issn_str_mv | 0066-4804, 1098-6596 |
language | English |
last_indexed | 2024-03-01T15:08:54.718Z |
match_str | aronoff1984comparativeactivitiesofthebetalactamaseinhibitorsytr830sodiumclavulanateandsulbactamcombinedwithamoxicillinorampicillin |
mega_collection | American Society for Microbiology (CrossRef) |
physical | 580-582 |
publishDate | 1984 |
publishDateSort | 1984 |
publisher | American Society for Microbiology |
record_format | ai |
recordtype | ai |
series | Antimicrobial Agents and Chemotherapy |
source_id | 49 |
spelling | Aronoff, S C Jacobs, M R Johenning, S Yamabe, S 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.26.4.580 <jats:p>YTR 830, a new beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam against aminopenicillin-resistant clinical isolates. At a concentration of 8 micrograms/ml, YTR 830 was as effective as clavulanate or sulbactam in reducing the aminopenicillin MICs. Combined with amoxicillin, YTR 830 is a potentially useful agent for therapy of many bacterial infections.</jats:p> Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin Antimicrobial Agents and Chemotherapy |
spellingShingle | Aronoff, S C, Jacobs, M R, Johenning, S, Yamabe, S, Antimicrobial Agents and Chemotherapy, Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin, Infectious Diseases, Pharmacology (medical), Pharmacology |
title | Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
title_full | Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
title_fullStr | Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
title_full_unstemmed | Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
title_short | Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
title_sort | comparative activities of the beta-lactamase inhibitors ytr 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
title_unstemmed | Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin |
topic | Infectious Diseases, Pharmacology (medical), Pharmacology |
url | http://dx.doi.org/10.1128/aac.26.4.580 |